Author/Authors :
Babarikins، Dmitrijs نويسنده Institute of Innovative Biomedical Technology, Inèukalna iela 2, Rîga, LATVIA; , , Krûmi?a، Guntra نويسنده nstitute of Innovative Biomedical Technology, Inèukalna iela 2, Rîga, LATVIA , , Paegle، Irina نويسنده Rîga Hospital of Traumatology and Orthopedics, Duntes iela 12/22, Rîga, LV-1013, LATVIA , , Amerika، Diâna نويسنده Pauls Stradi?? University Hospital, Latvian Transplantation Centre, Pilso?u iela 13, Rîga, LV-1002, LATVIA , , Krûmi?a، Zaiga نويسنده Institute of Innovative Biomedical Technology, Inèukalna iela 2, Rîga, LATVIA; , , Vanags، Dmitrijs نويسنده Institute of Innovative Biomedical Technology, Inèukalna iela 2, Rîga, LATVIA ,
Abstract :
Red beetroot (Beta vulgaris) juice (RBJ) is used as a traditional medicine for treatment of anemia.
It has been shown that beetroot juice decreases blood pressure, provides a protective effect on
blood vessels and has antioxidant and anticancerogenic properties. In the case of polytrauma it
might have beneficial effects because of its antioxidant and anti-inflammatory properties as well
as antimicrobial activity. It is also well-known that RBR juice can induce undesirable side effects,
e.g. flatulent stomach, nausea and other unpleasant reactions. Therefore, it seems prospective to
develop red beetroot juice based on its natural compound composition free of undesirable side effects,
which could then be used in combination with bone marrow multipotent mesenchymal
stromal cells (BM MMSC) transplantation in the case of polytrauma. The aim of the study was to
evaluate the therapeutic effect of allogeneic BM MMSC transplantation in rats with experimental
polytrauma and to analyse red beetroot fractions separated on the basis of molecular weight in
regard to their ingestion impact on cell transplantation efficacy. Red beet juice was fractionated
by ultrafiltration (cut-off-point 20 kDa). Total phenolic compound concentration in the final product
practically did not decrease. The product was tested in vitro and in vivo. Unlike native juice, fractionated
RBJ in vitro suppressed BM MMSC adipogenic (60–71%, P < 0.05) and stimulated
osteogenic differentiation (124%, P < 0.05). Experimental polytrauma in rats was modelled by
causing three fractures and haemorrhagic shock. Animals were randomised in five groups: 1) normal
control; 2) polytrauma; 3) polytrauma + i/v BM MMSC transplantation 36 h and 5 days after
surgery; 4) polytrauma + fractionated RBJ administration per os 1ml/d, and 5) polytrauma + BM
MMSCs + fractionated RBJ. Transplantation of allogeneic BM MMSCs in rats with experimental
polytrauma stimulated bone fracture reparation, but caused plethora in viscera and dystrophic
changes in lungs. Combination of BM MMSCs and fractionated RBJ resulted in better bone reparation
and significant hematopoiesis stimulation.